NeuroSense Therapeutics Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q2 2024 | -$0.05 | $0 | |||
| 03/29/2024 | Q1 2024 | -$0.35 | $0 | |||
| 04/04/2024 | Q4 2023 | -$0.19 | $0 | |||
| 09/29/2023 | Q3 2023 | $0.06 | $0 | |||
| 06/30/2023 | Q2 2023 | -$0.38 | $0 | |||
| 03/31/2023 | Q1 2023 | -$0.32 | $0 | |||
| 03/22/2023 | Q4 2022 | -$0.25 | $0 | |||
| 09/30/2022 | Q3 2022 | -$0.23 | $0 | |||
| 01/19/2023 | Q2 2022 | -$0.30 | $0 | |||
| 01/19/2023 | Q1 2022 | -$0.19 | $0 | |||
| 04/14/2022 | Q4 2021 | -$0.01 | $0 | |||
| 09/30/2021 | Q3 2021 | -$0.08 | $0 | |||
| 06/30/2021 | Q2 2021 | -$0.08 | $0 | |||
| 03/31/2021 | Q1 2021 | -$0.19 | $0 | |||
| 12/30/2020 | Q4 2020 | -$0.20 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.20 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.06 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.06 | $0 |
NeuroSense Therapeutics Ltd. Earnings: Frequently Asked Questions
-
How can I listen to NeuroSense Therapeutics Ltd.'s earnings conference call?
The conference call for NeuroSense Therapeutics Ltd.'s latest earnings report can be listened to online.
-
How can I read NeuroSense Therapeutics Ltd.'s conference call transcript?
The conference call transcript for NeuroSense Therapeutics Ltd.'s latest earnings report can be read online.
-
How much profit does NeuroSense Therapeutics Ltd. generate each year?
NeuroSense Therapeutics Ltd. (:NRSNW) has a recorded net income of $0. NeuroSense Therapeutics Ltd. has generated $-0.83 earnings per share over the last four quarters.
-
What is NeuroSense Therapeutics Ltd.'s price-to-earnings ratio?
NeuroSense Therapeutics Ltd. (:NRSNW) has a price-to-earnings ratio of -2.79 and price/earnings-to-growth ratio is -0.06.
